Markets - LS
Fascinating Life Science!
Another specialisation for us: Services to Life Science companies.
Biotechnology, pharmacy, med-tech and medical services. So important for our health. But such a difficult and long way from discovery of new agents to availability to the consumer.
Without sufficient capital there can be no research for new treatments or new molecules. And no development of medical science. Many new treatments are often developed by young biotech companies with no revenues to speak of.
Development costs skyrocket: it is estimated to cost about US$800 million to bring a new drug to the market. Some of this money can only be obtained from the capital markets, from patient investors, who understand the problems and the delays which face Life Science companies.
Companies that need to raise funds can find a large number of specialised funds in the European market: Specialised venture capital funds, Pharma-funds. Biotech-funds, healthcare-funds, med-tech-funds, medical device funds - as multifaceted as the sector itself. And where in Europe can you find these funds? That's where we can help you; that's our job ...
And why do we again believe to get better results for you? Since the beginning we have focused on life science sectors. We have organised numerous Life Science investor Roadshows, many One-on-Ones and Conference Calls 
with life science investors, life science analysts and the specialised Press right across Europe. We have the right contacts and our own Europe-wide data bases. Because we understand the way of thinking and the investment criteria and demands of these specialised investors. And because we take the trouble and the time to understand the business of our clients.
Have we awakened your interest? Contact us ...
Dr Reuter Investor Relations, Dr Eva Reuter, Germany call +49.251.71.32.862 or e.reuter(ad)dr-reuter.eu
Europe-Australia Investor, Trevor Baldock, France, call +33.608.787.104 or ltbaldock(ad)wanadoo.fr
